New York State enters its next phase of coronavirus vaccine distribution Monday, with millions more people eligible for their shots.
CBS2's John Dias has the latest.
Johnson & Johnson's COVID-19 Vaccine Is 66% Effective in Global Trial
Wibbitz Top Stories
Johnson & Johnson's
COVID-19 Vaccine Is
66% Effective in Global Trial.
The single-shot vaccine was found to be 66%..
